Current Path : /storage/v11800/affypharma/public_html/

Linux v11800 5.3.0-1023-aws #25~18.04.1-Ubuntu SMP Fri Jun 5 15:19:18 UTC 2020 aarch64

Upload File :
Current File : /storage/v11800/affypharma/public_html/zvc-tabs6.zip
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

DUSAM Lifesciences – Affy Pharma Pvt Ltd

GENERIC MARKETING

DUSAM Lifesciences

PODSAM

POWDER FOR ORAL SUSPENSION
30ML (HDPE BOTTLE)

Composition

Cefpodoxime 50mg/5ml

Indications & Uses

UTIs, LRTs

PODSAM-CV

POWDER FOR ORAL SUSPENSION
30ML (GLASS BOTTLE)

Composition

Cefpodoxime 50mg + Potassium Clavulanate 31.25mg/ 5ml

Indications & Uses

Upper & lower respiratory infections, Uncomplicated skin infections, Urinary Tract Infections

DUMOC-CLAV

POWDER FOR ORAL SUSPENSION
30ML (GLASS +HDPE BOTTLE)

Composition

Amoxycillin 200mg + Potassium Clavulunate 20.50mg/5ml

Indications & Uses

Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis, Upper Respiratory Tract Infections, Urinary Tract Infections

CEFSAM-CV

POWDER FOR ORAL SUSPENSION
30ML (GLASS BOTTLE)

Composition

Cefixime 50mg + Potassium clavulanate 31.25mg/5ml

Indications & Uses

Urinary Tract Inefctions, AECB, Otitis Media, Typhoid/p>

CEFSAM

POWDER FOR ORAL SUSPENSION
30ML (HDPE BOTTLE)

Composition

Cefixime 50mg/5ml

Indications & Uses

Urinary Tract Inefctions, Gastroenteritis

AZIVER SUSP

ORAL SUSPENSION
15 ml

Composition

Azithromycin 200mg/5ml

Indications & Uses

Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis,

INFLAX-DS

ORAL SUSPENSION
60 ml

Composition

Paracetamol 250mg/5ml

Indications & Uses

Fever, Pain

AMSPAS

ORAL SUSPENSION
60 ml

Composition

Paracetamol 125mg + Mefenamic Acid 50mg/5ml

Indications & Uses

Pain, Fever

PEPDUS

ORAL SUSPENSION
200ml

Composition

Cyproheptadine HCI 2mg + Tricholine citrate 0.275mg/5ml

Indications & Uses

Stimulate Apetite, Induces Weight Gain, Cure Allergies

ANCID – DSR

CAPSULES ( HARD GELATIN)
10X10 (Alu-Alu)

Composition

Pantoprazole 40mg (EC) + Domperidone 30mg (SR)

Indications & Uses

GERD, Dyspepsia, Acid Peptic Disorders, Gastritis

Zolex_DSR

CAPSULES ( HARD GELATIN)
11X10 (Alu-Alu)

Composition

Rabeprazole 20mg (EC) + Domperidone SR

Indications & Uses

GERD, Dyspepsia, Acid Peptic Disorders, Gastritis

ANCID – 40

INJECTION
40ml

Composition

Pantoprazole Sodium 40mg + NaCL

Indications & Uses

Acid-peptic disorders in hospitalized patients, Zollinger – Ellison Syndrome, Treatment of GERD Associated with Erasive Esophagitis, GL Bleed

DUSIC

SUSPENSION
170ml

Composition

Activated Dimethicone 25mg + Magnesium Hydroxide 200mg+ Aluminium Hydroxide Gel 200mg/10ml

Indications & Uses

Heartburn, Acid Indigestion

DUSZYME

SYRUP
200ml

Composition

Alpha Amylase (1:2000) 50mg, Pepsin(1:3000) 10mg/5ml

Indications & Uses

Dyspepsia, Flatulence, Anorexia, Pancreatic Insufficiency

HEMOLIC

CAPSULES (HARD GELATIN)
10X3X10

Composition

Vitamin C 75mg + Vitamin B12 5mcg + Carbonyl Iron 100mg + Folic Acid 1.5mg + Zinc Sulphate 61.8mg

Indications & Uses

Hyphocromic Anemia in Pregnancy, Chronic and / or Acute Blood Loss, Post-gynaesurgery, Iron Deficiency Anemia

SAM-D3 60K

CAPSULES (SOFT GELATIN)
10X1X4

Composition

Cholecalciferol 60000 UI

Indications & Uses

Osteoporosis, Osteoarthritis, Musculoskeletal Pain, Type- 2 Diabetes, Menstrual Irregularities, Pre-eclampsia, IUGR

DUSCAL-D3

ORAL SUSPENSION
200ml

Composition

Calcium Carbonate 625mg, Vitamin D3 125 IU/5ml

Indications & Uses

Osteomalacia, Osteoporosis, Fractures, Premenstrual Syndrome

DUSPOL

SYRUP (IRON TONIC)
300 ml

Composition

Iron (III) Hydroxide Polymaltose 50mg, Folic Acid 0.5mg/15ml

Indications & Uses

Pregnancy and lactation, Iron Deficiency Anaemia, Anaemia due to Excessive Haemorrhage, Anaemia Associated with Infections and Malignant Disease

DUSCAL

CAPSULES (SOFT GELATIN)
5X2X15

Composition

Calcitriol 0.25mcg + Calcium Carbonate 500mg + Zinc Sulphate 7.5mg

Indications & Uses

Osteoporosis, Hypoparathyroidism, Pregnancy & Lactation, Premenstrual Syndrome

AMSPAS-M

TABLETS
20X10

Composition

Mefenamic Acid 250mg + Dicyclomine HCI 10mg

Indications & Uses

Dysmenorrhea, Irritable Bowel Syndrome, Colic and Bladder Spasm, Abdominal Pain

DUSLAC

TABLETS (BLISTERS)
20X10

Composition

Nimeulide 100mg + Paracetamo; 325mg

Indications & Uses

Arthritis Pain, Soft Tissue Trauma Including Sprains, Musculoskeletal Pain, Pain Following Dental Extraction

PTSAM FORTE

TABLETS

20X10

Composition

Tramadol 37.5mg + Paracetamol 325mg

Indications & Uses

Chronic Back Pain, Osteoarthritis, Postoperative Pain

RESQ GEL

GEL
30g

Composition

Diclofenac Diethylamine 1.16% w/w + Oleum Linseed Oil 3 % w/w + Menthol 5% w/w +Methyl Salicylate 10% w/w

Indications & Uses

Sprains & Strains, Lower Back Pain, Joint Pain, Knee Pain

EATIC

CREAM
20g

Composition

Urea 10% +Lactic Acid 10% + Propylene Glycol 10% + Liquid Paraffin 10%

Indications & Uses

Foot Cracks, Keratolytic

CLOTI-X

OINTMENT
15g

Composition

Clotrimazole 1% w/w + Beclomethasone Dipropionate 0.025% w/w + Neomycin 0.5% w/w

Indications & Uses

Eczema, Psoriasis, Corticosteroid Responsive Dermatoses

KETODUS

LOTION
100 ml

Composition

Ketoconazole 2% w/v

Indications & Uses

Pityriasis, Dandruff

KETODUS-Z

LOTION
100 ml

Composition

Ketoconazole Shampoo 2% w/v + ZPTO 1% w/v

Indications & Uses

Pityriasis, Dandruff

KETODUS

SOAP
75g

Composition

Ketoconazole 1% w/w

Indications & Uses

Tinea Versicolor, Prophylaxis of Pityriasis Versicolor

FLUCDUS

TABLETS
20X1X1

Composition

Fluconazole 200mg

Indications & Uses

Vaginal Candidiasis, Brochopulmonary Infections, Candiduria, Tinea Pedis, Corposis, Cruris, Versicolor

DUSA-VIT

SYRUP
200ml

Composition

L-Iysine HCI 25mg + Vitamin B1 2.5mg + Vitamin B2 2.5mg + Vitamin B6 0.75mg + D-panthenol 3mg +Niacinamide 25mg + Mecobalamin 2mcg/10ml

Indications & Uses

Sub-optimal Growth, Poor Weight Gain, Malnutrition, Prolonged Illness

LYCODUS

SYRUP
225ml

Composition

Each 10ml Contains: Lycopene 6% 1000mcg + Vitamin A Palmitate 2500 IU + Vitamin E 10 IU + Ascorbic Acid 50mg + Selenium (as Sodium Selenate) 35mcg + Zinc (As Zinc Gluconate) 3mg + Manganese (as Manganese Gluconate) 2mg + Iodine ( As Potassium Iodine) 100mcg + Copper (As Copper Sulphate0 500mcg + Thiamine HCI 2mg + Riboflavine 3mg + Pyridoxine HCI 1.5mg

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

TARGI

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Antioxidant, Multivitamin & Multiminerals

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

TIVE

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Vitamin E (Natural) 400 IU + Wheat Germ Oil 100mg + Omega 3 Fatty Acids 30mg

Indications & Uses

Ulcerative colitis, Metabolic Syndrome, Rheumatoid Arthritis, Type-2 Diabetes, Cardiovascular Diseases

TARGI-4G

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Omega 3 Fatty Acid + Ginseng Extract + Ginkgo Bilaba Extract + Grape Seed Extract + Ginseng Extract + Multimineral + Multivitamin + Antioxidants + Trace Elements

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

TARGI-G

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Ginseng + Multivitamin + Multimineral

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

LYCODUS

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Each SG Contains Lycopene 6% 2000 IU + Vitamin A 2500 IU + Vitamin E Acetate 10 IU + Vitamin C 50 mg + Zinc sulphate Monohydrate 27.45mg + Selenium Dioxide 70mcg

Indications & Uses

Idiopathic Male Infertility, Pre-eclampsia, Prostate Cancer, Cardiovascular Diseases, Diabetes Mellitus

CEFSAM-200-LB

TABLETS (Alu-Alu)
20X10

Composition

Cefixime 200mg + Lactic Acid Bacilus 2.5 billion spores

Indications & Uses

Otitis Media, Pharyngitis & Tonsillitis, Uncomplicated Urinary Tract Infections, Acute Exacerbations of Chronic Bronchitis, Enteric Fever

CEFSAM-CV 325

TABLETS (Alu-Alu)
10X1X6

Composition

Cefixime 200mg + Potassium Clavulanate 125mg

Indications & Uses

Respiratory Tract Infections, Urinary Tract Infections, Skin & Skin Structure Infections

DUMOX CLAV-625

TABLETS (Alu-Alu)
10X1X6

Composition

Amoxycillin 500mg + Potassium Clavulanate 125mg

Indications & Uses

Respiratory Tract Infections, Community Acquired Pneumonia, Gynaecological Infections, Acute Exacerbations of Chronic Bronchitis, Skin and Soft Tissue Infections

T-OFLO-O

TABLETS (Blister)
20X10

Composition

Ofloxacin 200mg + Ornidazole 500mg

Indications & Uses

Surgical ions, Diarrheas of Mixed Etiology, Gynaecological Infections, Orofacial and Dental Infections

LEXA-500

TABLETS
10X10

Composition

Levofloxacin 500mg

Indications & Uses

Acute Bacterial Sinusitis, Acute Bacterial Exacerbations of Chronic Bronchitis, Skin & Skin Structure Infections, Chronic Bacterial Prostatitis, Urinary Tract Infections

CEFSAM-O

TABLETS (Alu-Alu)
20X10

Composition

Cefixime 200mg + Ofloxacin 200mg

Indications & Uses

Community Acquired Pneumonia, Multiple Drug Resistant-TB, Typhoid

T-OFLO

TABLETS (Alu-Alu)
20X10

Composition

Ofloxacin 200mg

Indications & Uses

Community Acquired Pneumonia, Multiple Drug Resistant-TB, Typhoid

DUMOX-CLAV 1.2

INJECTIONS
1.2g

Composition

Amoxycillin 1000mg + Potassium Clavulanate 200mg + WFI

Indications & Uses

Community Acquired Pneumonia, Gynaecological Infections, Upper Respiratory Tract Infections, Skin and Soft Tissue Infections, Urinary Tract Infections, Acute Exacerbations of Chronic Bronchitis

TREECEF-SB 1.5

INJECTIONS
1.5g

Composition

Ceftriaxone 1000mg + Sulbactam 500mg + WFI

Indications & Uses

Gynaecological Infections, Lower Respiratory Tract Infections, Intra-abdominal Infections with Aerobic Organisms, Surgical Prophylaxis

CEFOZ-S 1.5

INJECTIONS
1.5gm

Composition

Cefaperazone 1000mg + Sulbactam 500mg +WFI

Indications & Uses

Peritonitis, Bacterial Simusitis, Cholecystitis, Meningitis

MERODUS

INJECTIONS
1gm

Composition

Meropenem 1gm + WFI

Indications & Uses

Complicated Intra-abdominal Infection (cIAI), Complicated Skin & Skin Structure Infections (cSSSI), Bacterial Meningitis, Noscocomial Pneumonia

DUSTAZ-4.5

INJECTIONS
4.5gm

Composition

Piperacillin 4000mg + Tazobactam 500mg + WFI

Indications & Uses

Intra-abdominal Infections, Complicated Urinary Tract Infections, Febrile Neutropenia, Lower Respiratory Tract Infections

TREECEF-TZ 1.125

INJECTIONS
1.125gm

Composition

Ceftriaxone 1000mg + Tazobactam 500 mg + WFI

Indications & Uses

Bone & Joint Infections, Intra-abdominal Infections, Bacterial Meningitis, Pre-operative Surgical Prophylaxis

CUFDUS

SYRUP
100ml

Composition

Ambroxol HCI 15mg + Guaiphensin 50mg + Terbutaline Sulphate 1.5mg + Mentholated Base/5ml

Indications & Uses

Bronchitis, Productive Cough, Emphysema, Bronchial Asthma

CUFDUS-BR

SYRUP

100ml

Composition

Terbutaline Sulphate 1.25mg + Bromhexine HCI 4mg + Guaiphenesin 50mg + Methalated Base/5ml

Indications & Uses

Acute Cough, Abnormal Mucus Secretion, Productive Cough

DUDEX-CP

SYRUP
100ml

Composition

Dextromethorphan Hydrobromide 10mg + Phenylpherine 5 mg + Cetrizine 5mg + Mentholated Base/5ml

Indications & Uses

Commom Cold and Flu, Nasal Congestion, Sore Throat

LEVOMOM

TABLETS (Alu-Alu)
20X10

Composition

Levocetirizine 5mg + Montelukast 10mg

Indications & Uses

Allergic Rhinitis, Nasal Congestion, Asthma

LEVODUS

TABLETS (Alu-Alu)
20X11

Composition

Levocetirizine 5mg

Indications & Uses

Chronic Idiopathic Urticaria (CIU), Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR)

Arrange A Callback
[]
1 Step 1
Full Name
Telephone
Departmentyour full name
Postal Address
Message
0 /
Previous
Next
© 2024 Affy Pharma Pvt Ltd. All rights reserved. Designed by Zylon.
Shopping Basket